Safety and monitoring of allergen immunotherapy

Andrzej Emeryk; Małgorzata Bartkowiak-Emeryk

doi:10.5114/pja.2019.86348

eISSN: 2391-6052
ISSN: 2353-3854

Alergologia Polska - Polish Journal of Allergology

Current issue Archive Manuscripts accepted About the journal Editorial board Abstracting and indexing Subscription Contact Publication charge Supplements Special issues Instructions for authors Publication charge

Editorial System

Submit your Manuscript

Editorial Policies

Sarajevo Declaration on Integrity and Visibility of Scholarly Publications

Open access

2/2019
vol. 6

Send email

Copy url:

abstract:

Guidelines/recommendations

Safety and monitoring of allergen immunotherapy

Andrzej Emeryk

¹

,

Małgorzata Bartkowiak-Emeryk

²

Klinika Chorób Płuc i Reumatologii Dziecięcej, Uniwersytet Medyczny w Lublinie
Katedra i Zakład Immunologii Klinicznej, Uniwersytet Medyczny w Lublinie

Alergologia Polska – Polish Journal of Allergology 2019; 6, 2: 49-52

DOI: https://doi.org/10.5114/pja.2019.86348

Online publish date: 2019/07/09

View full text Get citation

PlumX metrics:

The article presents the factors determining the safety of allergen immunotherapy (AIT) in patients with allergic rhinitis, asthma and hymenoptera-sensitized venoms. The most important rules of conduct that increase the safety of AIT are given.

keywords:

Safety and monitoring of allergen immunotherapy

Andrzej Emeryk 1 , Małgorzata Bartkowiak-Emeryk 2

allergen immunotherapy, safety, monitoring, asthma, allergic rhinitis

Andrzej Emeryk

¹

,

Małgorzata Bartkowiak-Emeryk

²